Showing 521 - 540 results of 54,166 for search '(( 5 ((we decrease) OR (teer decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.23s Refine Results
  1. 521

    Image 2_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  2. 522

    Image 3_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”
  3. 523
  4. 524

    SMNΔ7 NMJs display a decrease in synaptic efficacy. by Karen K. Y. Ling (237660)

    Published 2010
    “…There is an increase in MEPP amplitude, a decrease in MEPP frequency and a reduction in quantal content in SMNΔ7 mice (n = 100–130 NMJs from 7 control and 10 SMNΔ7 mice; ***<i>p</i><0.0001, ** <i>p</i> = 0.007). …”
  5. 525
  6. 526
  7. 527
  8. 528

    GBE decreased secretion of Aβ1-40 in APP cells. by Virginie Rhein (243241)

    Published 2010
    “…Secreted Aβ1-40 was significantly decreased in GBE-treated APP cells (100 µg/ml; 24 h). …”
  9. 529
  10. 530
  11. 531
  12. 532

    Decreased mitochondrial reactive oxygen species in Aβ resistant cells. by Jordan T. Newington (223389)

    Published 2011
    “…This decrease in ROS was maintained with 48 hr Aβ (20 µM) exposure. …”
  13. 533

    Inhibition of PSMA decreases pathologic angiogenesis in a mouse model of OIR. by Christina L. Grant (315488)

    Published 2013
    “…<p><b>A</b>) Wild type mice undergoing OIR were treated systemically with either a single dose of 100mg/kg 2-PMPA on P14 (n = 3, <b>center</b>) or three daily doses from P14 through P16 (n = 6, <b>right</b>), controls received vehicle (PBS, <b>left</b>). …”
  14. 534

    Phosphopeptides with predicted MAPK site that showed decreased abundance in 1NM-PP1-treated <i>mak-2<sup>Q100G</sup></i> cells. by Wilfried Jonkers (160931)

    Published 2014
    “…</p>3<p>Showed reduced expression in a <i>mak-2<sup>Q100G</sup></i> germlings treated with 1NM-PP1 (19).…”
  15. 535

    Image_5_A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial.TIF by Stephan Thurau (10213218)

    Published 2022
    “…Systemic and intraocular application of KIO-100 (PP-001) (previously called PP-001, now KIO-100) could efficiently suppress rat uveitis in a preventive as well as therapeutic mode. …”
  16. 536
  17. 537
  18. 538
  19. 539

    New Horizons in Micro/Nanoplastic-Induced Oxidative Stress: Overlooked Free Radical Contributions and Microbial Metabolic Dysregulations in Anaerobic Digestion by Xingxing Zhang (173950)

    Published 2024
    “…The formation of <sup>•</sup>OH enhanced ROS production by 86.2–100.9%, resulting in decreased cellular viability and methane production (by 37.5–50.5%) at 100 mg/g TS PP-MPs/NPs. …”
  20. 540